Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin‐induced miosis and visual impairment in rats. (May 2014)
- Record Type:
- Journal Article
- Title:
- Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin‐induced miosis and visual impairment in rats. (May 2014)
- Main Title:
- Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin‐induced miosis and visual impairment in rats
- Authors:
- Gore, A
Bloch‐Shilderman, E
Egoz, I
Turetz, J
Brandeis, R - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12586-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>Eye exposure to the organophosphorus (OP) irreversible cholinesterase inhibitor sarin results in long‐term miosis and impaired visual function. We have previously shown that tropicamide is better at ameliorating this insult than topical atropine or cyclopentolate. However, to minimize side effects associated with repeated tropicamide applications and high treatment doses, we evaluated the effects of oximes (ChE re‐activators) alone and combined with tropicamide at ameliorating OP‐induced ocular impairments.</p> </sec> <sec id="bph12586-sec-0002" sec-type="section"> <title>Experimental approach</title> <p>Rats were topically exposed to sarin, followed by topical treatment with various oximes alone or in combination with tropicamide. Pupil width and light reflex were measured by an infrared‐based digital photograph system, while visual performance was assessed by employing the cueing version of the Morris water maze (MWM).</p> </sec> <sec id="bph12586-sec-0003" sec-type="section"> <title>Key Results</title> <p>Oxime treatment following sarin ocular exposure induced a slow persistent pupil widening with efficacy in the order of HLö‐7 &gt; HI‐6 &gt; obidoxime = TMB‐4 = MMB‐4. In the light reflex test, the ability of the iris to contract following oxime treatment was mostly impaired at 1 h and was back to<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12586-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>Eye exposure to the organophosphorus (OP) irreversible cholinesterase inhibitor sarin results in long‐term miosis and impaired visual function. We have previously shown that tropicamide is better at ameliorating this insult than topical atropine or cyclopentolate. However, to minimize side effects associated with repeated tropicamide applications and high treatment doses, we evaluated the effects of oximes (ChE re‐activators) alone and combined with tropicamide at ameliorating OP‐induced ocular impairments.</p> </sec> <sec id="bph12586-sec-0002" sec-type="section"> <title>Experimental approach</title> <p>Rats were topically exposed to sarin, followed by topical treatment with various oximes alone or in combination with tropicamide. Pupil width and light reflex were measured by an infrared‐based digital photograph system, while visual performance was assessed by employing the cueing version of the Morris water maze (MWM).</p> </sec> <sec id="bph12586-sec-0003" sec-type="section"> <title>Key Results</title> <p>Oxime treatment following sarin ocular exposure induced a slow persistent pupil widening with efficacy in the order of HLö‐7 &gt; HI‐6 &gt; obidoxime = TMB‐4 = MMB‐4. In the light reflex test, the ability of the iris to contract following oxime treatment was mostly impaired at 1 h and was back to normal at 4 h following sarin exposure. All oxime treatments ameliorated the sarin‐induced visual impairment as tested in the visual task (MWM). The combined topical treatment of tropicamide with an oxime induced a rapid improvement in pupil widening, light reflex and visual performance, and enabled a reduction in tropicamide dose.</p> </sec> <sec id="bph12586-sec-0004" sec-type="section"> <title>Conclusions and Implications</title> <p>The use of tropicamide combined with an oxime should be considered as the topical treatment of choice against the toxic effects of ocular OP exposure.</p> </sec> </abstract> … (more)
- Is Part Of:
- British journal of pharmacology. Volume 171:Number 9(2014:May)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 171:Number 9(2014:May)
- Issue Display:
- Volume 171, Issue 9 (2014)
- Year:
- 2014
- Volume:
- 171
- Issue:
- 9
- Issue Sort Value:
- 2014-0171-0009-0000
- Page Start:
- 2364
- Page End:
- 2374
- Publication Date:
- 2014-05
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.12586 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3859.xml